强化剂量阿托伐他汀对不稳定型心绞痛患者PCI围手术期B7-H3、B7-H4的影响
DOI:
作者:
作者单位:

(1.广西医科大学第一附属医院心血管内科,广西南宁市 530021;2.广西中医药大学第一附属医院中西医结合心血管内科,广西南宁市 530021;3.玉林市红十字会医院心血管内科,广西玉林市 537000;4.益阳医学高等专科学校附属医院内一科,湖南省益阳市 413000;5.永州市中心医院心血管内科,湖南省永州市 425000)

作者简介:

吕静,硕士研究生,研究方向为心脑血管疾病诊治新方法、新技术,E-mail为estellelv@126.com。

通讯作者:

基金项目:

广西科学研究与技术开发计划项目(科技攻关1355005-4-6)


Effect of intensive dose atorvastatin on B7-H3, B7-H4 in patients with unstable angina pectoris undergoing percutaneous coronary intervention
Author:
Affiliation:

1.Department of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China;2.Department of Cardiology, the First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi 530021, China;3.Department of Cardiology, the Red Cross Hospital of Yulin City, Yulin, Guangxi 537000, China;4.Department of Cardiology, Affiliated Hospital of Yiyang Medical College, Yiyang, Hunan 413000, China;5.Department of Cardiology, Central Hospital of Yongzhou, Yongzhou, Hunan 425000, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨强化剂量阿托伐他汀对不稳定型心绞痛患者经皮冠状动脉介入治疗(PCI)围手术期B7-H3和B7-H4表达的影响。 方法 将80例不稳定型心绞痛患者随机分为常规剂量组(阿托伐他汀20 mg/d,n=40)和强化剂量组(阿托伐他汀80 mg/d,n=40),分别于PCI术前和术后18~24 h收集外周静脉血,采用ELISA检测外周血白细胞介素4(IL-4)、白细胞介素10(IL-10)、干扰素γ(IFN-γ)、血清可溶性B7-H3(sB7-H3)、可溶性B7-H4(sB7-H4)水平,用实时荧光定量PCR检测外周血单核细胞B7-H3、B7-H4 mRNA相对表达量。 结果 两组患者PCI术后IL-10、sB7-H3、sB7-H4水平和B7-H3、B7-H4的mRNA表达水平均较术前升高,其中强化剂量组升高更显著(P<0.05)。相反,两组患者PCI术后IL-4、IFN-γ水平均降低,且强化剂量组较常规剂量组下降更明显(P<0.05)。 结论强化剂量阿托伐他汀可能通过促进B7-H3、B7-H4表达,从而降低不稳定型心绞痛患者PCI术后免疫炎症反应。

    Abstract:

    Aim To investigate the effect of intensive dose atorvastatin therapy on B7-H3, B7-H4 in peripheral blood monocytes of patients with unstable angina pectoris undergoing percutaneous coronary intervention (PCI). Methods The patients with unstable angina pectoris were randomly divided into conventional dose group (atorvastatin 20 mg/d, n=40) and intensive dose group (atorvastatin 80 mg/d, n=40), peripheral blood were collected before and 18 h ~ 24 h after PCI. Enzyme-linked immunosorbent assay was used to detect peripheral blood IL-4, IL-10, IFN-γ and sB7-H3, sB7-H4, fluorescence-based quantitive real-time PCR was used to measure B7-H3 and B7-H4 mRNA. Results The levels of IL-10, sB7-H3, sB7-H4 and the expression of B7-H3 and B7-H4 mRNA in the two groups after PCI were higher than those before PCI, and the increase of the intensive dose group was more significant than that of the conventional dose group (P<0.05). On the contrary, the levels of IL-4 and IFN-γ in the two groups after PCI were decreased, and the decrease of the intensive dose group was more obvious than that of the conventional dose group (P<0.05). Conclusion Intensive dose atorvastatin may promote the expression of B7-H3 and B7-H4, thereby reducing the immune inflammation in patients with unstable angina pectoris after PCI.

    参考文献
    相似文献
    引证文献
引用本文

吕静,徐戈,黄琛,雷敏,张晶晶,马冰宁.强化剂量阿托伐他汀对不稳定型心绞痛患者PCI围手术期B7-H3、B7-H4的影响[J].中国动脉硬化杂志,2017,25(6):590~593.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2016-09-05
  • 最后修改日期:2016-12-11
  • 录用日期:
  • 在线发布日期: 2017-06-05